News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Alliances
Novogen Limited (NVGN) And Feinstein Institute Join Forces To Find Effective Treatments For Brain Cancer 4/17/2015
Takeda (TKPYY) Bets $269 Million+ with CiRA for 100-Scientist 10-Year Stem Cell R&D Pact 4/17/2015
NeuroVive Chooses New Stroke Partner After To-BBB's Restructuring and Collaboration Concludes 4/17/2015
Panther Biotechnology Announces New Drug Candidate To Selectively Kill Leukemia Stem Cells 4/17/2015
Igantia Therapeutics Partners With Fogarty Institute Of Innovation 4/17/2015
Theranostics Health Announces Agreements With Avera Health For Research Collaborations And Coverage Of Theralink Assay 4/17/2015
4SC Pockets €95 Million Upfront From Resminostat Deal With Menarini Asia-Pacific Group (Formerly Invida Group) 4/17/2015
IBM (IBM)'s New Boston Health Unit Will House 2,000 Employees 4/16/2015
Pfizer (PFE)'s Screening Process Sorts the Legit Partnerships From the Casual Flings 4/16/2015
Genmab A/S (GEN.CO) Achieves USD 10 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 4/16/2015
Regeneron (REGN) CEO Heads to Cuba With N.Y. Trade Delegation 4/16/2015
Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY) 4/16/2015
Immunocore Limited And MedImmune (AZN) Announce New Collaboration To Conduct Immuno-Oncology Combination Trails In Melanoma 4/16/2015
Lancet And ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 4/16/2015
Pivotal Therapeutics Inc. Executes Memorandum Of Understanding For Exclusive Distribution Of Benefishial Line Of Products In Korea 4/16/2015
Autifony Therapeutics Announces £3.3 Million Collaboration To Progress First-In-Class Drug For Schizophrenia Into Clinical Trials 4/16/2015
Asklepios BioPharmaceutical, Inc. Executes License With Benitec Limited (BLT.AX) 4/16/2015
NovaBay Pharmaceuticals, Inc. (NBY) Signs Distribution Agreement With AmerisourceBergen Corporation (ABC) For Avenova 4/16/2015
RainDance Technologies Extends Global Commercial Reach With Distributor Appointments In Europe And Middle East 4/16/2015
SillaJen Announces Agreement With The FDA For A Special Protocol Assessment For Upcoming Phase 3 Pexa-Vec Trial In Advanced Liver Cancer 4/16/2015
Quintiles (Q) And Hospital Italiano Of Buenos Aires Announce Agreement To Accelerate Clinical Development 4/16/2015
BioCision, LLC And Brooks Joint Development Partnership To Unveil New Cryogenic Sample Handling And Transport Product 4/16/2015
GeoVax Labs Inc. (GOVX.OB) Enters Into Research Collaboration Agreement With The NIH For Ebola/Marburg Vaccines 4/16/2015
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $14 Million Research Expansion With Genzyme (GENZ) 4/16/2015
H. Lundbeck A/S (LUN.CO) And Ovid Technologies Announce Exclusive Worldwide Licensing Agreement For Gaboxadol 4/16/2015
The ALS Association, Harvard Stem Cell Institute, And Massachusetts General Hospital Neurological Clinical Research Institute Collaborate With GlaxoSmithKline (GSK) On New ALS Clinical Trial 4/16/2015
Coherus And Baxter International (BAX) Announce Amendment To Etanercept Biosimilar Collaboration Agreement 4/15/2015
Heart Metabolics Limited And FDA Reach Agreement On Special Protocol Assessment For Single Phase 3 Trial Of Perhexiline In Hypertrophic Cardiomyopathy 4/15/2015
SELLAS Life Sciences Group And Trojantec Ltd. Sign Exclusive License Agreement For Global Rights On Development And Commercialization Of Innovative TR-1 Anti-Cancer Antennapedia Technology 4/15/2015
Ophthalmology-Focused CROs, Iris Pharma And Oculos Clinical Research Announce Strategic Alliance To Offer International Specialized Services To The Ophthalmic Market 4/15/2015
IBBL Joins Forces With Europe’s Biggest Players In Cancer Research 4/15/2015
China's NHWA Pharma To Start Trial Of In-Licensed Epilepsy Drug 4/15/2015
Guided Therapeutics, Inc. Books Investment, Signs MOU With Potential China Distributor 4/15/2015
Florida Atlantic University Signs Collaboration Agreement With Internationally Renowned Nansen Neuroscience Network In Norway 4/15/2015
Heart Metabolics And FDA Reach Agreement On Special Protocol Assessment For Single Phase 3 Trial Of Perhexiline In Hypertrophic Cardiomyopathy 4/15/2015
Optibrium And ChemAxon Announce Technology Collaboration 4/15/2015
Lexicon Pharmaceuticals, Inc. (LXRX) And Bristol-Myers Squibb (BMY) Select Development Candidate For Neuropathic Pain In Neuroscience Drug Discovery And Development Alliance 4/15/2015
Argos Therapeutics, Inc. (ARGS) Licenses Arcelis Technology Platform To Lummy HK For Development Of Personalized Immunotherapies To Treat Cancer In China 4/15/2015
Celgene (CELG), Mesoblast (MSB.AX) $45M Deal "Speaks Volumes" About Big Pharma's Cell Therapy Plans, Says Pluristem Therapeutics (PSTI) 4/14/2015
BioReference Laboratories, Inc. (BRLI) Partners With Organizations Accelerating Medical Innovation 4/14/2015
Pressure BioSciences, Inc. (BBII) To Collaborate With Southern University At New Orleans On Improving And Extending The Use Of PBI's PCT Platform For The Detection Of DNA In Forensic Samples 4/14/2015
Multiple Myeloma Research Foundation (MMRF), University Of Torino, And Adaptive Biotechnologies Work To Speed Novel Minimal Residual Disease Monitoring Technologies To Patients 4/14/2015
IBM (IBM) & Apple (AAPL) Expand Partnership To Help Transform Medical Research 4/14/2015
THERAVECTYS Secures Exclusive Access To A Synthetic Humanized Nanobody Library From Institut Curie And Strengthens Its Proprietary Immunotherapeutic Platform 4/14/2015
Abbott (ABT) And Sekisui Collaborate To Offer Coagulation Testing For Laboratories Worldwide 4/14/2015
Lead Discovery Center And AstraZeneca PLC (AZN) Broaden Drug Discovery Alliance 4/14/2015
UMBC Partnership With Northrop Grumman (NOC) Expands To Include Health Data Analytics 4/14/2015
Recipharm AB Makes Strategic Investment In Synthonics And Partners In Development Of Novel Compounds 4/14/2015
Aptuit LLC And Axxam SpA Announce Strategic Alliance For Integrated Drug Discovery Services 4/14/2015
REGiMMUNE Announces Collaboration With Juvenile Diabetes Research Foundation And Pfizer (PFE) For Type 1 Diabetes Prevention And Treatment Promoting Regulatory T-Cells 4/14/2015
Elevance Expands Customer Service And Support Capabilities In U.S. And Europe For Elevance Aria WTP 40 Customers 4/14/2015
Mesoblast (MSB.AX) Hits Highest Point in a Decade, as Celgene (CELG) Bets $45 Million 4/13/2015
PharmAthene, Inc. (PIP) Receives $5.8 Million Payment From BARDA 4/13/2015
Hydra Biosciences, Inc. And Boehringer Ingelheim Enter Research Collaboration Focused On Renal Diseases And Disorders 4/13/2015
PatientsLikeMe And AstraZeneca PLC (AZN) Announce Global Research Collaboration 4/13/2015
Humabs BioMed Reports Clinical Milestone In MedImmune (AZN) Partnership 4/13/2015
Affymetrix (Santa Clara, California) (AFFX) And Evergene Ltd., A Subsidiary Of MTI Ltd., Collaborate In Genetic Research And Personal Genomics Services In Japan 4/13/2015
Medivir AB (MVRBF) And Cancer Research Technology Collaborate To Develop New Class Of Cancer Drugs 4/13/2015
TVM Capital Life Science Announces Initiation Of Investment Operations Of China Biopharma Capital I Venture Capital Fund, With First Close Of $50 Million 4/13/2015
TRACON Pharmaceuticals, Inc. (TCON) Expands License Agreement And Signs Research Agreement With Case Western Reserve University 4/9/2015
BioXcel And Takeda (TKPYY) Partner To Repurpose Assets For Orphan Diseases 4/9/2015
Amyris, Inc. And Squalan Natural Health Partner To Accelerate Development And Sales Of Neossance Personal Care Products 4/9/2015
Arvinas Strikes $434 Million Collaboration with Merck & Co. (MRK) to Continue Thriving in Connecticut 4/8/2015
Targacept (TRGT), Catalyst Biosciences Merger in Jeopardy After Pfizer (PFE) Pulls Plug on Deal 4/8/2015
Ipsen (IPN.PA) And Hannover Medical School Start Joint Research In Recombinant Botulinum Neurotoxins For Targeted Secretion Inhibitors 4/8/2015
Compass Point Research To Collaborate With NDA Partners To Develop Migraine Combination Drug 4/8/2015
Orgenesis Signs Cell Therapy Product Development Memorandum Of Understanding With CureCell Of Korea 4/8/2015
AmorChem l.p. Invests In Projects At The Personalized Cancer Immunotherapy Program 4/8/2015
Inovio Pharmaceuticals (INO) Selected By Defense Advanced Research Projects Agency To Lead A $45 Million Program To Expedite Development Of Novel Products To Prevent And Treat Disease Caused By Ebola 4/8/2015
REGENXBIO Licenses Key Technologies From University of Pennsylvania And University of Minnesota For The Development Of Treatments For MPS I And MPS II 4/8/2015
Merus Reaches Pivotal Milestone In Bispecific Antibody Collaboration With Ono Pharmaceutical Company, Ltd. 4/8/2015
Cortendo AB Joins National Organization for Rare Disorders (NORD) Corporate Council 4/8/2015
F2G License Cresset’s Forge To Complement Successful Consulting Projects 4/8/2015
Padlock Therapeutics Initiates Collaborations With Three Leading Research Partners On The Biology Of PAD Enzymes 4/8/2015
PPD, Inc. (PPDI) And SNBL Complete Joint Venture To Provide Japanese Clinical Development Services And Additional Collaborations 4/8/2015
uniQure (QURE) Soars After Bristol-Myers Squibb (BMY) Bets $1 Billion on Gene Therapy Platform 4/7/2015
Caris Life Sciences And COTA Enter Collaboration To Measure Clinical And Economic Impact Of Evidenced-Based Drug Selection For Precision Medicine In Oncology 4/7/2015
VBI Vaccines Announces Research Collaboration With Sanofi Pasteur (SASY.PA) To Enhance Vaccine Stability 4/7/2015
Taxus Cardium (CRXM) Announces Agreement With Dr. Reddy's Laboratories Ltd. (RDY) To Co-Develop, Market & Sell Generx Angiogenic Microvascular Gene Therapy In Certain International Markets 4/7/2015
Breakout Labs And Becton, Dickinson and Company (BDX) Partner To Provide Capital And Expertise To Biomedical Startups 4/7/2015
Amphivena Therapeutics Achieves Development Milestones Under Agreement With Janssen Biotech Inc. (JNJ) 4/7/2015
Vernalis PLC (VNLPY.PK) Enters Into Research Collaboration With Taisho Pharmaceutical 4/7/2015
Global Strategic Partners Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) Finalize Agreement To Co-Promote XALKORI (Crizotinib) 4/7/2015
Our Vision Is To Cure Alzheimer’s Disease: Health Connexions And Recombinant Technologies Announce A Ground-Breaking Partnership To Accelerate Success In Alzheimer’s Disease 4/7/2015
DSG, Inc. Partners With Soligenix (SNGX) To Battle Cutaneous T-Cell Lymphoma 4/7/2015
Phylogica Ltd. Enters Transaction With UK Biotech To Identify And Develop Small Molecule Cancer Drugs 4/7/2015
Orgenesis To Collaborate With The Global Stem Cell & Regenerative Medicine Acceleration Center Of Korea 4/7/2015
Advaxis, Inc. And RTOG Foundation To Collaborate On Pivotal Phase 2/3 Clinical Trial Of ADXS-HPV In Anal Cancer 4/6/2015
ProtoKinetix Inc. (PKTX.OB) Announces Consulting Agreements 4/6/2015
Cytori Therapeutics, Inc. (CYTX) Receives China Opening Product Purchase Order From Licensee 4/6/2015
MorphoSys AG CEO Believes Drug Isn't Dead Even After Celgene (CELG) Abandons $818 Million Pact 4/6/2015
Radlink Announces Exclusive Sales Agency Agreement With Johnson & Johnson (JNJ) Subsidiary DePuy Synthes Companies 4/3/2015
MD Anderson Cancer Center, Astellas Pharma Inc. (ALPMY) Sign Option Agreement For Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia 4/3/2015
BIND Therapeutics (BIND) Announces Extension Of Global Collaboration With Pfizer (PFE) To Develop And Commercialize Multiple Accurins 4/3/2015
Sanofi (SAN.PA) Inks a $120 Million Drug Design Pact to Help Guide Lackluster Drug Discovery Programs 4/2/2015
Quintiles (Q), Quest Diagnostics (DGX) to Combine and Form Global Clinical Trial Lab Joint Venture 4/2/2015
Intrexon Corporation Signs Cooperative Research And Development Agreement (CRADA) With The National Cancer Institute For RheoSwitch Controlled IL-12 Cancer Therapies Using T Cell Receptors (TCR) Derived From Peripheral Blood 4/2/2015
OncoMed Pharmaceuticals, Inc. (OMED) And Eli Lilly (LLY) Enter Clinical Supply Agreement To Evaluate The Combination Of Demcizumab And Alimta (Pemetrexed For Injection) In Lung Cancer 4/2/2015
Nektar Therapeutics (NKTR) Announces Receipt Of $100 Million Milestone Payment From AstraZeneca PLC (AZN) 4/2/2015
Cold Spring Harbor Laboratory And North Shore-LIJ Announce Strategic Affiliation To Accelerate Benefits Of Cancer Research To Patients 4/2/2015
Sanford-Burnham Medical Licenses Small Molecule To Daiichi Sankyo For Further Development 4/2/2015
Baxter International (BAX) And Laboratoire Aguettant Announce Global Collaboration For Parenteral Nutrition Trace Elements 4/2/2015
Peptidream Announces License Of PeptiDream's Peptide Discovery Platform System (PDPS) Technology To Peptidream 4/2/2015
Ipsen (IPN.PA) Expands Ties To Harvard University With Signing Of A New Research Alliance Agreement 4/2/2015
BioMed Realty Forms New Relationship With Stanford Health Care With New 138,000 Square Foot Lease At Pacific Research Center 4/2/2015
MultiCorp International, Inc. Engages Compass Point Research To Collaborate With NDA Partners To Develop Patented Migraine Combination Drug 4/2/2015
Massachusetts Biotechnology Council, Inc. Announces New Collaborations With Science, Banker & Tradesman & DrugPatentWatch 4/2/2015
Tiny Aduro Biotech Snags $750M Cancer Deal With Drug Giant Novartis AG (NVS) 4/1/2015
Covance Inc. (CVD) And Sihuan Pharmaceutical Initiate Partnership In Preclinical And Clinical Portfolio Development 4/1/2015
VLP Therapeutics Enters Collaboration With Institute Of Tropical Medicine, Nagasaki University 4/1/2015
Portage Biotech's Biohaven Announces Agreement With inVentiv Health (VTIV) 4/1/2015
Teijin Limited Signs Sales Agreement For New Anti-inflammatory Analgesic Patch Formulation 4/1/2015
Brickell Biotech Signs Exclusive License And Development Agreement For BBI-4000 With Kaken Pharmaceuticals 4/1/2015
Stellar Biotechnologies, Inc. And Neovacs SA Expand KLH Supply Relationship 4/1/2015
Panther Biotechnology Announces Exclusive License Agreement With Northwestern University 4/1/2015
Myriad Genetics, Inc. (MYGN) And AstraZeneca PLC (AZN) Expand Research Collaboration On Lynparza 4/1/2015
Neurocrine Biosciences, Inc. (NBIX) And Mitsubishi Tanabe Pharma Corporation Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets 4/1/2015
Merck Serono, Intrexon Corporation Ink $941M Pact, As Race for CAR-T Edge Continues 3/31/2015
Teva (TEVA) Wins $170 Million Contract To Make Vaccine In Forest 3/31/2015
Syndax Pharmaceuticals Inc. And Merck & Co. (MRK) To Collaborate On Immuno-Oncology Study Evaluating Entinostat In Combination With KEYTRUDA (Pembrolizumab) In Lung Cancer And Melanoma 3/31/2015
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards Clinic 3/31/2015
AEterna Zentaris (AEZS) Signs Transfer Agreement Of Its Discovery Library With The Medical University of South Carolina 3/31/2015
Biocryst Pharmaceuticals (BCRX) Awarded BCX4430 Advanced Development Contract 3/31/2015
Bayer HealthCare (BAY) Expands Collaboration With Broad Institute Of MIT And Harvard University To Develop Therapies For Cardiovascular Disease 3/31/2015
Merck And China Animal Husbandry Sign Partnership MOU 3/31/2015
Lead Discovery Center And Helmholtz Centre for Infection Research Enter Partnership For The Discovery Of New Drugs Against Multi-Resistant Bacteria 3/31/2015
Cold Spring Harbor Laboratory Engages Hairpin Technologies Inc. To License Its Short Hairpin RNA (shRNA) Technology 3/31/2015
Quintiles (Q) And Quest Diagnostics (DGX) To Form Joint Venture To Provide Global Clinical Trials Laboratory Services 3/31/2015
X-Chem And Navitor Pharmaceuticals Enter Into License Agreement On Novel Small Molecules Targeting mTORC1 Activation 3/31/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
The Biopharmaceutical Business Of Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Intrexon Corporation Announce Agreement For The Development And Commercialization Of CAR-T Therapy 3/30/2015
Aegerion (AEGR) Reaches Agreement With Sarissa Capital 3/30/2015
Baxter International (BAX) Expands Access To Healthcare Through Collaborations And Charitable Giving 3/30/2015
SCIEX And Mass Consortium Corporation Announce Exclusive Reseller Agreement Of XCMSplus Metabolomics Software 3/30/2015
Cell Therapy Catapult Signs Multiple Collaboration Agreements 3/30/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
RXi Pharmaceuticals (RXII) And Mirimmune LLC Enter Into An Exclusive Licensing Agreement For RXi's Self-Delivering RNAi (sd-rxRNA) Technology To Develop Cell-Based Immunotherapies To Treat Cancer 3/27/2015
Google (GOOG)'s Mystery Biotech Calico Cuts Local Longevity R&D Pact 3/26/2015
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licence Of Anamorelin In China, Hong Kong And Macao 3/26/2015
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015
Orion Corporation Signs Cooperation Agreement With HUCH Comprehensive Cancer Center 3/26/2015
CluePoints And ACRES Partner To Improve Data Quality In Clinical Research 3/26/2015
Probi Signs Agreement With Leading VMS Supplier In Canada 3/26/2015
Asahi Kasei Pharma (AHKSY.PK) Selects Evotec AG (EVTG.F) As Its Partner For Ion Channel Drug Discovery 3/26/2015
Evolva A/S And Valent BioSciences Corporation To Co-Develop Agricultural Bioactives 3/26/2015
Green Cross And Nanolek Announce Strategic Partnership For Biologics Commercialisation In Russia 3/26/2015
OXIS International, Inc. (OXIS) Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh 3/26/2015
Shire (SHPGY) And Cincinnati Children's Hospital Medical Center's Establish Rare Disease Research Collaboration 3/26/2015
Ablynx (ABLYF) Announces Extension Of Ion Channel Research Collaboration With Merck & Co. (MRK) 3/26/2015
MorphoSys AG And Celgene (CELG) Mutually Agree To End MOR202 Collaboration 3/26/2015
Recipharm AB And Adroit Science Form Collaboration To Expand Service Offering 3/26/2015
Merck & Co. (MRK) Announces Collaboration With American Diabetes Association To Educate Adults With Diabetes About Increased Risk For Serious Diseases Like Pneumococcal Pneumonia 3/26/2015
Lycera Announces Milestone In Merck & Co. (MRK) Collaboration 3/25/2015
Signum Dermalogix Out-Licenses SIG990 To Dermata Therapeutics For Topical Treatment of Rosacea 3/25/2015
Novasep And Celladon Corporation Execute MYDICAR API Supply Agreement 3/25/2015
Avalanche Biotechnologies (AAVL) And The University of Washington Enter Into Exclusive License Agreement To Develop Gene Therapy Medicines To Treat Color Blindness 3/25/2015
Bellerophon Therapeutics (BLPH) Selects Flextronics (FLEX) To Manufacture The Mark2, Next-Generation Inopulse Device 3/25/2015
Phosphagenics Limited (POH.AX) Signs License Agreement To Expand TPM-Based Animal Nutrition Products To The UK And Ireland 3/25/2015
Cancer Research UK Cambridge Research Institute And Medidata Solutions, Inc. Partner To Streamline Data Collection And Management For Cancer Clinical Trials 3/25/2015
The Institut Pasteur Announces An Alliance With Integragen To Strengthen Its High-Throughput Sequencing Activities In Microbiology 3/25/2015
Taconic Biosciences And Cellaria Biosciences Agree To Scientific Collaboration To Facilitate Xenograft Use In Oncology Research 3/25/2015
Emergent BioSolutions (EBS) Awarded $31 Million Contract For Advanced Development Of Nuthrax, A Next Generation Anthrax Vaccine 3/24/2015
Biocept, Inc. (BIOC) Enters Clinical Collaboration With University of California, San Diego (UCSD) Moores Cancer Center 3/24/2015
USPTO Issues Positive Decision That Triggers Royalty Payments To Neptune Technologies & Bioressources Inc. 3/24/2015
TB Alliance Announces Partnership With U.S. Fund For UNICEF To Increase Access To Impending New Child-Friendly TB Treatments 3/24/2015
Denator AB Enters Into Collaboration With Newly Established State-Of-The-Art European Institute For Clinical Applications 3/24/2015
Mercachem Choose Cresset’s Torch And Spark Molecule Design Software To Support Their Growing Medicinal Chemistry Service Business 3/24/2015
ABL Awarded National Cancer Institute Contract To Continue Groundbreaking Retroviral Research 3/24/2015
Ocata Therapeutics Licenses Induced Pluripotent Stem Cell Technology From Allele Biotechnology And Extends Leadership Position In Cell Therapy Capabilities 3/24/2015
Qu Biologics Begins Research Collaboration With University of Rochester, New York 3/24/2015
Probi AB And Wageningen University Enter Long-Term Research Collaboration 3/24/2015
Portage Biotech's Biohaven Enters Into Exclusive Formulation Agreement And Global License With Catalent Pharma Solutions (CTLT) For Lead Product 3/24/2015
Affimed Therapeutics AG (AFMD) Completes Tandab Development Candidate Activities Meeting Amphivena's And Janssen Biotech Inc. (JNJ)'s Criteria And Achieves Milestone Ahead Of Schedule 3/24/2015
Stemedica Cell Technologies, Inc. Obtains An Exclusive Worldwide License For Stem Cell Stabilization And Preservation Technologies 3/24/2015
ImmunoGen (IMGN) Jumps After Reaching $220 Million Cancer Deal With Takeda (TKPYY) 3/23/2015
Another Day, Another $456 Million Cancer Pact for Eli Lilly (LLY) 3/23/2015
Clontech Laboratories, Inc. Signs Agreement With Ludwig Cancer Research For Access To Smart-Seq2 3/23/2015
Pfizer (PFE) Pockets $200 Million as Tanezumab Phase III Program With Eli Lilly (LLY) Resumes 3/23/2015
Can-Fite BioPharma (CFBI) Signs Multi-Million Dollar Distribution Agreement For CF101 In Canada With Cipher Pharmaceuticals (DND.TO) 3/23/2015
GenVec Inc. (GNVC) And TheraBiologics Form Collaboration To Develop Neural Stem Cell Mediated Cancer Therapies 3/23/2015
Yew Bio-Pharm Group Signs Sales Agreement And Receives Subsidy Grant From The Finance Department Of Heilongjiang Province, China 3/23/2015
Prime Therapeutics Selects EQuIPP As Platform For Collaboration With Community Pharmacies For Continuous Improvement Of Quality 3/23/2015
Week In Review: China's Innovent And Eli Lilly (LLY) Form $456 Million Cancer Biologics Alliance 3/23/2015
Zai Lab In-licenses Potential Liver Cancer Drug From Bristol-Myers Squibb (BMY) 3/23/2015
Cold Spring Harbor Laboratory And GlaxoSmithKline (GSK) To Develop Diabetes And Obesity Therapeutic 3/23/2015
Horizon Discovery Group plc And ArcherDX Sign OEM Agreement 3/23/2015
ICON And Carnegie Mellon University Collaborate to Evaluate Patient-Centric Informed Consent Processes 3/23/2015
ISA Scientific, Yissum Ltd., Hadasit Ltd., And The Kennedy Trust For Rheumatology Research To Collaborate On Treating Diabetes And Other Serious Health Conditions With Cannabidiol 3/23/2015
Confluence Pharmaceuticals Signs Co-Development And Marketing Agreement With AOP Orphan Pharmaceuticals AG For Fragile X Syndrome Drug 3/23/2015
Evotec AG (EVTG.F) Inherits Sanofi (SAN.PA)'s Troubled Division in €250 Million Long Term Drug Discovery Deal 3/20/2015
Celgene (CELG)'s Deal-Making Guru About to Find Out If His Strategy Works or Not 3/20/2015
Intarcia Therapeutics, Inc. And Numab AG Sign Multi-Asset Collaboration To Develop Once-Yearly Therapies In Diabetes, Obesity, and Autoimmune Indications 3/20/2015
Vaccinex, Inc. Signs Multi-Target Antibody Discovery Deal With Five Prime Therapeutics, Inc. (FPRX) 3/20/2015
New England Biolabs, Inc. And Benchling Collaborate To Simplify Golden Gate Assemblies 3/20/2015
The Dow Chemical Company (DOW) Expands Partnership With FIRST To Promote STEM Education 3/20/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Chooses PharmaCell As Contract Manufacturing Partner For Its Phase III Program In Europe 3/20/2015
National Institute For Occupational Safety And Health Partners With Protea Biosciences, Inc. 3/20/2015
The Cooperative Research Centre for Cell Therapy Manufacturing Release: International Regenerative Medicine Groups Form Strategic Alliance To Commercialize Cell Therapies 3/20/2015
Eli Lilly (LLY), Hanmi Pharma Forge $690 Million Autoimmune Pact 3/19/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Establishes Manufacturing Agreement With Pharmacell B.V. For European Production Of ICT-107 For Phase 3 Registration Trial 3/19/2015